Stock Earnings

Question 1

Aridis Pharmaceuticals Incの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、Aridis Pharmaceuticals Incの総資産は$14で、純lossは$-30です。

Question 2

ARDSの主要な財務比率は何ですか？

Accepted Answer

Aridis Pharmaceuticals Incの流動比率は0.36、純利益率は-1,000、1株当たり売上高は$0.15です。

Question 3

Aridis Pharmaceuticals Incの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

Currently Aridis Pharmaceuticals Inc data is not available.

Question 4

Aridis Pharmaceuticals Incは収益を上げていますか？

Accepted Answer

no、最新の財務諸表によると、Aridis Pharmaceuticals Incの純lossは$-30です。

Question 5

Aridis Pharmaceuticals Incに負債はありますか？

Accepted Answer

yes、Aridis Pharmaceuticals Incの負債は38です。

Question 6

Aridis Pharmaceuticals Incの発行済株式数は何株ですか？

Accepted Answer

Aridis Pharmaceuticals Incの総発行済株式数は27.03株です。

Breakdown	TTM	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	22	3	1	1	1	2
Revenue Growth (YoY)	1,000%	200%	0%	0%	-50%	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	5	7	7	6	6	3
Research & Development	17	25	36	16	24	23
Operating Expenses	23	33	44	23	30	26
Other Non Operating Income (Expenses)	0	0	0	--	--	1
Pretax Income	-1	-30	-42	-22	-29	-22
Income Tax Expense	--	--	--	--	--	--
Net Income	-1	-30	-46	-22	-29	-23
Net Income Growth	-97%	-35%	109%	-24%	26%	-15%
Shares Outstanding (Diluted)	37.42	18.77	12.29	9.17	8.46	8.11
Shares Change (YoY)	111%	53%	34%	8%	4%	3%
EPS (Diluted)	-0.03	-1.61	-3.77	-2.44	-3.51	-2.89
EPS Growth	-98%	-56.99%	55%	-30%	21%	-17%
Free Cash Flow	-17	-29	-23	-20	-8	-24
Free Cash Flow Per Share	-0.45	-1.54	-1.87	-2.18	-0.94	-2.95
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	-966.66%	-4,200%	-2,200%	-2,900%	-1,200%
Profit Margin	-4.54%	-1,000%	-4,600%	-2,200%	-2,900%	-1,150%
Free Cash Flow Margin	-77.27%	-966.66%	-2,300%	-2,000%	-800%	-1,200%
EBITDA	0	-29	-42	-22	-29	-24
EBITDA Margin	0%	-966.66%	-4,200%	-2,200%	-2,900%	-1,200%
D&A For EBITDA	0	0	0	0	0	0
EBIT	0	-29	-42	-22	-29	-24
EBIT Margin	0%	-966.66%	-4,200%	-2,200%	-2,900%	-1,200%
Effective Tax Rate	--	--	--	--	--	--

Aridis Pharmaceuticals Inc (ARDS) Price